Augmentin antibiotic drug

Augmentin antibiotic drug

C015/5237 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 50.3MB

Downloadable file size: 668.2KB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Augmentin antibiotic drug. Box containing co-amoxiclav powder, marketed under the name Augmentin, for oral administration. Co-amoxiclav is a combination drug containing amoxicillin (a penicillin antibiotic) and the beta-lactamase inhibitor clavulanic acid. It was developed in the 1970s by the British pharmaceutical company Beecham. This packet has been produced by GlaxoSmithKline. The combination of amoxicillin with clavulanic acid increases the spectrum of infections the drug can be used against, allowing its use against bacteria that are resistant to amoxicillin.

Release details: Model release not required. Property release not available.

Keywords: 125mg/5ml, amoxicillin, amoxycillin, anti-bacterial, antibacterial, antibiotic, antibiotics, augmentin, beta-lactamase inhibitor, biochemical, biochemistry, broad spectrum, broad-spectrum, chemical, chemistry, clavulanic acid, close-up, co-amoxyclav, combination, combined, detail, drug, drugs, glaxosmithkline, healthcare, medical, medication, medicine, oral suspension, packaged, packaging, penicillin, pharmaceutical, pharmaceutics, pharmacological, pharmacology, powder, prescribed, prescription, still life, still-life, treatment, white background

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.